Chemotherapy with cisplatin and paclitaxel in patients with locally advanced, recurrent or metastatic oesophageal cancer.
about
Bi-weekly chemotherapy of paclitaxel and cisplatin in patients with metastatic or recurrent esophageal cancer.Phase II study of weekly paclitaxel and capecitabine in patients with metastatic or recurrent esophageal squamous cell carcinoma.New developments in the treatment of esophageal cancer.Phase I trial of weekly cisplatin, irinotecan and paclitaxel in patients with advanced gastrointestinal cancerEstimation of an optimal radiotherapy utilization rate for gastrointestinal carcinoma: a review of the evidence.Management of oesophageal cancer.Palliative therapy.Recent developments in the systemic therapy of advanced gastroesophageal malignancies.Phase II trial of docetaxel, cisplatin and fluorouracil followed by carboplatin and radiotherapy in locally advanced oesophageal cancerPhase II study of bi-weekly administration of paclitaxel and cisplatin in patients with advanced oesophageal cancerSecond-line therapy for esophageal cancer.Nanoparticle albumin-bound paclitaxel combined with cisplatin as the first-line treatment for metastatic esophageal squamous cell carcinomaPharmacotherapy for oesophagogastric cancer.Paclitaxel plus cisplatin vs. 5-fluorouracil plus cisplatin as first-line treatment for patients with advanced squamous cell esophageal cancer.Supra-additive effect with concurrent paclitaxel and cisplatin in vulvar squamous cell carcinoma in vitro.Anti-EGFR-Targeted Therapy for Esophageal and Gastric Cancers: An Evolving Concept.A phase I/II study of oxaliplatin and paclitaxel in patients with non-resectable cancer of the oesophagus and adenocarcinoma of the gastro-oesophageal junction: a study of the Arbeitsgemeinschaft Internistische Onkologie.Esophageal cancer chemotherapy: recent advances.A multi-center phase II study of docetaxel plus cisplatin as first-line therapy in patients with metastatic squamous cell esophageal cancer.Docetaxel and cisplatin as first-line treatment for patients with metastatic esophageal cancer: a pilot study.Patterns of distant organ metastases in esophageal cancer: a population-based study.Selection of a patient subgroup with advanced esophageal squamous carcinoma who could benefit from second-line chemotherapy.96-hour paclitaxel infusions: at least 93 hours too long.
P2860
Q33367836-518B0EB8-B689-4D68-95A6-B87711DF4FCCQ34010159-286CED39-6FB6-4655-998A-85912BE05034Q34590804-389F86A1-E69B-4BC7-8927-E1C84F28CD82Q35559881-8A5CB082-57B0-4505-A315-0691EDC4885DQ35860636-DF2DCF31-25D7-4C64-9534-87882D6CFAF3Q36262306-FD8C3108-A9C3-45E0-802B-AD3E2C9D4D59Q36318354-08D0482E-BC62-404D-9E08-4013C98C0047Q36376439-ABCD9FA1-8A68-4AFD-A326-25E4B5F4038DQ36609800-ED08510D-A701-4D61-8679-B8C31A9DD5B6Q36644156-C839C21D-1CA2-4972-845D-D48206AC61C0Q36842786-F16685F1-31CD-40AE-8F24-8D68CB27403DQ36891363-FAF93578-D71F-48AF-9A1B-D1F2160B2E2FQ37011966-FCAA13B6-5258-4798-A693-2C4576CFD1E6Q37382552-4FEE1B82-546E-409A-8016-7A2C60CA90E2Q40718608-AD6EFE94-03DA-41FC-A6F5-2833A253AE28Q42119902-E2BF768F-DAE3-48CA-91E0-5314196533C0Q43114221-129EE83C-99AA-420E-897C-40FD7FB2A676Q43194164-0413496D-3893-4D2F-9AC2-DC0AEB6F92A5Q43274899-DD5A364F-437D-4510-BA67-5883110C4481Q44159329-DA9B1E94-2237-453C-A577-FFDB82FD644EQ47118283-FBD2D1E6-733C-46F0-B2FC-013F5336F1ECQ53259440-41E0D1FE-32FE-4680-9A54-D1CCDA4393DFQ53915465-A7206507-2F4A-470F-BA6B-502092857ACF
P2860
Chemotherapy with cisplatin and paclitaxel in patients with locally advanced, recurrent or metastatic oesophageal cancer.
description
1998 nî lūn-bûn
@nan
1998 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Chemotherapy with cisplatin an ...... metastatic oesophageal cancer.
@ast
Chemotherapy with cisplatin an ...... metastatic oesophageal cancer.
@en
type
label
Chemotherapy with cisplatin an ...... metastatic oesophageal cancer.
@ast
Chemotherapy with cisplatin an ...... metastatic oesophageal cancer.
@en
prefLabel
Chemotherapy with cisplatin an ...... metastatic oesophageal cancer.
@ast
Chemotherapy with cisplatin an ...... metastatic oesophageal cancer.
@en
P2093
P2860
P356
P1476
Chemotherapy with cisplatin an ...... metastatic oesophageal cancer.
@en
P2093
P2860
P2888
P304
P356
10.1038/BJC.1998.524
P407
P577
1998-08-01T00:00:00Z
P5875
P6179
1035200185